Skip to content

Intergard IGW0026-15Recalls & reported problems

Intervascular Sas · Intergard Woven Straight Collagen Coated Vascular Graft · Class 2 · Implant

Adverse event reports
4
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00384401000211), received between Jan 3, 2018 and Oct 23, 2025 — classified as 1 injury, 3 malfunctions.

The most frequently reported specific device problem is “Product Quality Problem” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K984294); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 2 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Product Quality Problem2
  • Device Damaged Prior to Use1
  • Manufacturing, Packaging or Shipping Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Blood Loss1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 23, 2025Product Quality Problem; Product Quality Problem

    COMPLAINT #: (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23368433 ↗
  • MalfunctionOct 23, 2025Product Quality Problem; Product Quality Problem

    COMPLAINT # (B)(4)

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23368425 ↗
  • MalfunctionFeb 17, 2022Device Damaged Prior to Use; Device Damaged Prior to Use

    THE EXTERNAL PACKAGING OF THE PRODUCT WAS TORN/ DENTED. THE PRODUCT WAS NOT IMPLANTED, THEREFORE NO PATIENT WAS HARMED. COMPLAINT # (B)(4).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13547620 ↗
  • InjuryJan 3, 2018Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem

    IT WAS REPORTED THAT ON (B)(6) 2017, A SEVERE BLOODLOSS OCCURED THROUGH THE WALL OF THE PROSTHESIS DURING AN AORTIC ASCENDA WITH HEMIARCH PROCEDURE. THE BLEEDING WAS STOPPED BY APPLYING HEMOSTATIC AGENTS (GELITA X-SORB ) AND ADMINISTRATION OF COAGULATION DRUG (OCTAPLEX - 2 DOSES), THE SURGERY WAS SIGNIFICANTLY PROLONGED AND BLOOD TRANSFUSION WAS REQUIRED. THE GRAFT REMAINED IMPLANTED, THE PATIENT STAYED 4 DAYS AT ICU. NO CONSEQUENCE FOR PATIENT WAS REPORTED.

    Patient problems: Blood Loss

    MAUDE report 7160015 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K984294. One submission often covers many models, so check the product and lot details in each record.

  • Z-1282-2022 · Apr 29, 2022 · Terminated
    INTERGARD Woven Vascular Graft is a woven polyester graft coated with a bovine collagen. It has an external velour surface and non-velour inner surface. The device is available in

Other Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices

All Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.